(Total Views: 97)
Posted On: 12/15/2020 1:30:47 PM
Post# of 27112
$RFL News Article - UPDATE - Rafael Pharmaceuticals Receives FDA Fast Track Designation for CPI-613 (devimistat) for the Treatment of Acute Myeloid Leukemia (AML) https://marketwirenews.com/news-releases/upda...86692.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
